Payment Disclosure

CLINICAL RESEARCH ADVANTAGE INC

$11,297
paid by Boehringer Ingelheim »
Listed practitioner: Gerald R Shockey
Location: Mesa, Ariz.
Payment for: Research
Payment for: Research
Reported: Jan. to Dec. 2013
Search for CLINICAL RESEARCH ADVANTAGE INC in Prescriber Checkup, our database of prescribing patterns within Medicare's drug program.

Notable drugs produced by Boehringer Ingelheim include:

Spiriva (Bronchoplasm caused by emphysema, chronic bronchitis, or COPD)
Micardis (High blood pressure)
Pradaxa (Blood clots, reduces risk of stroke)
Combivent (COPD)
Atrovent (Chronic bronchitis, emphysema, asthma attacks)
Aggrenox (Prevents strokes in patients with blood flow disorders or blood clots)
Catapres (High blood pressure, ADHD)
Tradjenta (Type 2 diabetes)
Gilotrif (Metastatic non-small cell lung cancer)
Mirapex (Parkinson disease, restless legs syndrome)
Viramune (HIV)
Aptivus (HIV)

Important notes

Research payments are distinct from speaking and consulting. The figure listed does not reflect the actual compensation received by the physician listed as the principal investigator.

Payments for clinical studies may include costs associated with patient care, supplies, as well as the time spent by health care professionals treating patients and managing the study.

The reports include both the name of the health provider who performed the service and, when reported, the entity paid. They may be different.

Source: Boehringer Ingelheim. ProPublica last downloaded this record on Sept. 9, 2014.

I think this is my doctor — what should I do?

If your provider is listed, it’s because a drug company reported paying him or her for promotional activities, meals, travel, educational items, consulting or research. Such payments are legal, but research has shown that drug-company marketing can influence what a doctor prescribes. How you can use this data »